An investigation in the medical journal BMJ faults the U.S. Food and Drug Administration for its tepid response to reports that diabetes drugs including Byetta and Januvia may be linked to pancreatitis and pancreatic cancer.
Both the FDA and the European Medicines Agency are conducting investigations into that class of drugs, called incretin mimetics, the story says. And both agencies have confirmed that their own analyses show increased reporting or signals ...
continue reading...